6.18.01: Medical Technology Issue
Four analysts and top management from twenty sector firms examine the Medical Technology sector in this special 98-page issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Investing in the Second Biotechnology Revolution Conference Issue & Specialty Pharmaceuticals Report

  1. Small-Cap Med-Tech Stocks - In an in-depth (5,000 words) Analyst Interview, Frederick Wise, Managing Director at Bear, Stearns & Co., examines the outlook for the sector and shares specific stock recommendations
  2. Medical Technology: Small Cap Stocks - In an in-depth (3,400 words) Analyst Interview, Hans von der Luft, Senior Vice President at McDonald Investments, Inc., examines the outlook for the sector and shares specific stock recommendations
  3. Small Cap Medical Supply & Devices - In an in-depth (4,100 words) Analyst Interview, Dr. David Gruber, Senior Vice President and Rosanne Ott, Research Analyst, both at Lehman Brothers, examine the outlook for the sector and share specific stock recommendations
  4. CEO interviews (average 2,500 words). Top management of twenty sector firms examine the outlook for their firm and the sector. Firms include:
    Nymox Pharmaceuticals, Acculmage Diagnostics, Align Technology, Bionx Implants, Cambridge Heart, Curon Medical, DiaSys, Fischer Imaging, Interleukin Genetics, Interpore Cross International, Matritech, Milestone Scientific, QMed, QuadraMed, Rad-Source, Smith & Nephew, SonoSite, Sonus Pharmaceuticals, Symbollon, ZEVEX International
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE